Pharmaceutical & Biotech Biotech Investor Relations CEO Time: Balancing Investor Demands With Scientific Leadership
How biotech CEOs balance investor relations time demands with scientific leadership, maintaining capital market credibility without losing R&D focus.
Pharmaceutical & Biotech